Treatment success results among AN/AI (sustained virologic response at 12 weeks post treatment) by intention-to-treat and per-protocol analyses with 95% confidence intervals [CI], Alaska, treated March 2014- December 2018.

Treatment success results among AN/AI (sustained virologic response at 12 weeks post treatment) by intention-to-treat and per-protocol analyses with 95% confidence intervals [CI], Alaska, treated March 2014- December 2018.2014年3月至2018年12月阿拉斯加地区接受治疗的AN/AI人群的治疗成功结果，以治疗后12周持续病毒学应答（sustained virologic response at 12 weeks post treatment）作为判定标准，采用意向治疗（intention-to-treat）与符合方案（per-protocol）分析方法，并附带95%置信区间（95% confidence intervals, CI）。